Molecular Assemblies, Inc. is a private biotechnology company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high-quality, sequence-specific DNA reliably, affordably, and sustainably. Molecular Assemblies’ technology will unleash a new generation of DNA synthesis for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $64.3M
Founded date: 2013
Investors 4
| Date | Name | Website |
| - | iSelect Fu... | iselectfun... |
| - | 11.2 Capit... | 112capital... |
| - | DCVC | dcvc.com/ |
| - | Argonautic | argonautic... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 16.03.2022 | Series B | $25.8M | - |
| 15.04.2021 | Series A | $24M | - |
| 01.10.2019 | Series A | $12.2M | - |
| 12.12.2016 | Seed | $2.3M | - |
Mentions in press and media 17
| Date | Title | Description |
| 12.03.2024 | iSelect: Pioneering the Future of Food, Health, and Technology | At iSelect, we recognized early on the impending crisis of diabetes, obesity, and rising healthcare costs, identifying poor nutrition as a core culprit. Since 2014, our mission has been clear: to leverage innovation in agriculture and healt... |
| 28.09.2022 | We Solved Y2K, We’ll Solve #FoodIsHealth, Innovation is Better | When faced with the challenge of Y2K, the computer industry realized innovation is better. The turn of the millennium in 2000 was supposed to be an exciting event. Instead, for the IT and internet communities, it was a looming disaster. Tha... |
| 15.03.2022 | Springboard and Cool Co, Molecular Assemblies acquires $25.8M in Series B financing to develop enzymatic DNA synthesis technology and begin a Key Customer Program | - |
| 15.03.2022 | Molecular Assemblies Gains $25.8M For DNA Synthesis | San Diego-based Molecular Assemblies, a company developing enzymatic DNA synthesis technology, announced this morning that it has raised $25.8M in its Series B financing round. The funding included Casdin Capital, plus Agilent Technologies,... |
| 15.04.2021 | Molecular Assemblies has raised additional funding to bring the total of their Series A funding round to $24M | - |
| 15.04.2021 | Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access | |
| 15.04.2021 | Molecular Assemblies Closes $24M Series A | SAN DIEGO, CA, Molecular Assemblies has closed an oversubscribed $24 million Series A. >> Click here for more funding data on Molecular Assemblies >> To export Molecular Assemblies funding data to PDF and Excel, click here ... |
| 15.04.2021 | Molecular Assemblies Picks Up $24M For DNA Synthesis | San Diego-based Molecular Assemblies said this morning that it has raised $24M in a Series A funding round, which came from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures, as well as LYF... |
| 17.12.2020 | Slone Partners Places Phil Paik, Ph.D., as Vice President, Platform Development, at Molecular Assemblies | “Dr. Paik is an experienced industry leader who brings a track record of success over many years,” said Slone Partners President Tara Kochis-Stach. SOUTH RIDING, Va. (PRWEB) December 17, 2020 Slone Partners, a nationwide executive search fi... |
| 18.08.2020 | Investing with Impact Without Sacrificing Performance | Impact investing has grown up. Originally associated with environmental and sustainability causes, the concept is now expanding to include diversity issues, social impact, healthcare and food access and more. Today, it’s about investing in ... |
Show more